First, M R <br/><br/>
Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune.  [electronic resource] 

 -  Transplantation proceedings   
 - 324-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/s0041-1345(98)01646-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Chemistry, Pharmaceutical<br/>Cyclosporine--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Kidney Transplantation--immunology<br/>Metabolic Clearance Rate<br/>Time Factors